Significant reduction in end‐stage liver diseases burden through the national viral hepatitis therapy program in Taiwan

Publisher： John Wiley & Sons Inc

E-ISSN： 1527-3350|61|4|1154-1162

ISSN： 0270-9139

Source： HEPATOLOGY, Vol.61, Iss.4, 2015-04, pp. : 1154-1162

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

United Network for Organ Sharing regional variations in appeal denial rates with non‐standard Model for End‐Stage Liver Disease/Pediatric End‐Stage Liver Disease exceptions: support for a national review board

By  

CLINICAL TRANSPLANTATION (ELECTRONIC), Vol. 29, Iss. 6, 2015-06 ,pp. : 513-522

John Wiley & Sons Inc

Access to resources Recommend Favorite

Myelodysplasia-Like Syndrome and End-Stage Liver Disease

By  

Acta Haematologica, Vol. 105, Iss. 2, 2001-06 ,pp. : 100-102

Karger

Access to resources Recommend Favorite

Antidiabetic Therapy in End‐Stage Renal Disease

By  

SEMINARS IN DIALYSIS, Vol. 28, Iss. 4, 2015-07 ,pp. : 337-344

John Wiley & Sons Inc

Access to resources Recommend Favorite

A novel integrated Model for End‐Stage Liver Disease model predicts short‐term prognosis of hepatitis B virus‐related acute‐on‐chronic liver failure patients

By  

HEPATOLOGY RESEARCH, Vol. 45, Iss. 4, 2015-04 ,pp. : 405-414

John Wiley & Sons Inc

Access to resources Recommend Favorite

Antibody Response to Hepatitis B Vaccine in End-Stage Renal Disease Patients

By  

Nephron Clin Pract, Vol. 103, Iss. 3, 2006-03 ,pp. : c89-c93

Karger

Access to resources Recommend Favorite